Literature DB >> 27656253

Pregnancy outcomes in a patient with Sjögren's disease with renal involvement.

Abhishek Joshi1, Keelin O'Donoghue2, Uzma Mahmood2, Debasish Banerjee3, Anita Banerjee1.   

Abstract

BACKGROUND: Maternal and fetal outcome in pregnancy with renal failure is unpredictable, where each condition can adversely affect the other. We present a case of steroid sensitive Sjögren's nephritis worsened by pregnancy, demonstrated over the course of multiple pregnancies and investigated the aetiology. CASE: A 28-year-old nullipara with a diagnosis of primary Sjögren's syndrome presented with a deterioration of renal function. A diagnosis of secondary tubulo-interstitial nephritis was made on renal biopsy. Her first pregnancy ended in the second trimester with a decision to deliver a female infant at 27 weeks due to worsening maternal renal function. Renal function improved immediately. A second pregnancy ended in a first trimester miscarriage. The third and fourth pregnancies delivered male infants at 35 and 34 weeks, with worsening renal function in each pregnancy, reaching end stage. Repeat biopsy showed extensive glomerulosclerosis and male cells were identified.
CONCLUSIONS: This case of Sjögren's syndrome with renal disease demonstrated the increased risk of fetal and maternal adverse pregnancy outcomes. Renal function worsened in each pregnancy and progressed to end-stage renal disease. Fetal microchimerism offers an interesting mechanism for our patient's renal failure and its apparent relationship to her pregnancies.

Entities:  

Keywords:  Maternal-fetal medicine; immunology; nephrology; rheumatology

Year:  2013        PMID: 27656253      PMCID: PMC5004321          DOI: 10.1177/1753495X13487323

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  17 in total

1.  Y chromosome microchimerism in rheumatic autoimmune disease.

Authors:  Y Miyashita; M Ono; M Ono; H Ueki; K Kurasawa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

2.  Pregnancy outcome in patients with primary Sjögren's syndrome. a case-control study.

Authors:  Hans-Jacob Haga; Clara Gram Gjesdal; Hege Svean Koksvik; Johan Fredrik Skomsvoll; Lorentz M Irgens; Monika Ostensen
Journal:  J Rheumatol       Date:  2005-09       Impact factor: 4.666

3.  Detection of maternal-fetal microchimerism in the inflammatory lesions of patients with Sjögren's syndrome.

Authors:  M Kuroki; A Okayama; S Nakamura; T Sasaki; K Murai; R Shiba; M Shinohara; H Tsubouchi
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome.

Authors:  Sélim Aractingi; Jean Sibilia; Véronique Meignin; David Launay; Eric Hachulla; Caroline Le Danff; Anne Janin; Xavier Mariette
Journal:  Arthritis Rheum       Date:  2002-04

5.  Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome.

Authors:  Y Endo; I Negishi; O Ishikawa
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

6.  Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study.

Authors:  C P Mavragani; U G Dafni; A G Tzioufas; H M Moutsopoulos
Journal:  Br J Rheumatol       Date:  1998-07

7.  Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome.

Authors:  I Kaufman; D Schwartz; D Caspi; D Paran
Journal:  Scand J Rheumatol       Date:  2008 May-Jun       Impact factor: 3.641

8.  Fetal outcome in women with primary Sjögren's syndrome. A retrospective case-control study.

Authors:  H Julkunen; R Kaaja; P Kurki; T Palosuo; C Friman
Journal:  Clin Exp Rheumatol       Date:  1995 Jan-Feb       Impact factor: 4.473

9.  Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren's syndrome.

Authors:  Fatma Ulku Adam; Dilek Torun; Filiz Bolat; Aysegul Zumrutdal; Siren Sezer; Fatma Nurhan Ozdemir
Journal:  Clin Rheumatol       Date:  2005-05-26       Impact factor: 3.650

10.  Pregnancy and the risk of autoimmune disease.

Authors:  Ali S Khashan; Louise C Kenny; Thomas M Laursen; Uzma Mahmood; Preben B Mortensen; Tine B Henriksen; Keelin O'Donoghue
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.